Acme Generics LLP

Founded in 2005, Acme Group is a leader in contract manufacturing and a preferred partner for top Indian and global pharma companies, specializing in female sex hormones, levothyroxine tablets, and liquid and lyophilized injectables. With more than 2,500 staff and over 500,000 sq ft of manufacturing space in Northern India, Acme produces 17 billion tablets, 3 billion capsules, 30 million liquid vials/ampoules and 12 million lyophilized vials annually, meeting regulatory approvals from USFDA, UK MHRA, EU GMP, TGA Australia and Health Canada, among others.